Seeing Is Believing
Currently out of the existing stock ratings of William Tanner, 9 are a HOLD (24.32%), 26 are a BUY (70.27%), 2 are a SELL (5.41%).
Analyst William Tanner, carries an average stock price target met ratio of 57.9% that have a potential upside of 33.68% achieved within 510 days.
William Tanner’s has documented 76 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on NVAX, Novavax at 15-Jun-2021.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 7/7/2020. The price target of $148 was fulfilled within 21 days with a profit of $43.44 (41.55%) receiving and performance score of 19.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$25
$15.54 (164.27%)
$31
11 months 23 days ago
(16-Oct-2024)
0/4 (0%)
$14.85 (146.31%)
Sell
$9
$-0.46 (-4.86%)
$27
1 years 1 months 27 days ago
(12-Aug-2024)
6/7 (85.71%)
$-2.85 (-24.05%)
53
Buy
$25
$15.54 (164.27%)
$11
1 years 2 months 7 days ago
(02-Aug-2024)
16/38 (42.11%)
$13.22 (112.22%)
72
Hold
$12
$2.54 (26.85%)
$13
1 years 4 months 29 days ago
(10-May-2024)
4/4 (100%)
$3.12 (35.14%)
172
Buy
$35
$25.54 (269.98%)
2 years 4 months 29 days ago
(10-May-2023)
13/18 (72.22%)
$26.01 (289.32%)
176
What Year was the first public recommendation made by William Tanner?